Sign In
Buy ALLR
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigati
The Schall Law Firm Is Investigating Allarity Therapeutics For Securities Fraud And Invites Investors To Join
11:00am, Sunday, 18'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therap
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR
10:30pm, Saturday, 17'th Aug 2024
NEW YORK , Aug. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR). Such investors are
The Schall Law Firm Is Looking Into Allarity Therapeutics For Securities Fraud And Encourages Shareholders To Join
11:00am, Saturday, 17'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therap
NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigati
The Schall Law Firm's Allarity Therapeutics Inc Securities Fraud Investigation Is Open For ALLR Investors
04:00pm, Thursday, 15'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (NASDA
The Schall Law Firm's Allarity Therapeutics Inc Securities Fraud Investigation Is Available For ALLR Investors
07:00pm, Wednesday, 14'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therap
NEW YORK , Aug. 14, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating cl
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Allarity Therapeut
Allarity Therapeutics Inc Securities Fraud Investigation By The Schall Law Firm Is Open For ALLR Investors
08:00pm, Tuesday, 13'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (NASDA
The Schall Law Firm Opens Securities Fraud Investigation Into Allarity Therapeutics Inc For ALLR Investors
11:00pm, Monday, 12'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therap
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR
10:00am, Sunday, 11'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR). Such investors ar
The Schall Law Firm Opens Securities Fraud Investigation Of Allarity Therapeutics Inc To ALLR Investors
09:00pm, Friday, 09'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therape
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR
11:45am, Friday, 09'th Aug 2024
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR). Such investors are ad
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (
